NEW YORK — The generics industry, which filled more than 90% of prescriptions and delivered $445 billion in savings in 2023, faces a pivotal moment as it grapples with supply chain pressures and financial sustainability challenges.
Join us on Tuesday, July 8, 2025, at 1:00 PM EDT for Generics at a Crossroad, a free, one-hour webcast featuring industry leaders from Ascend Laboratories, one of the top 10 suppliers in the sector.
Register now to secure your spot and stay ahead in the evolving healthcare landscape.
Register here
The discussion will explore:
- The current state of the generics business
- Challenges in bringing generic drugs to market
- Necessary changes for the long-term health of the industry
- What sets Ascend apart in a competitive landscape
Speakers include:
- John Dillaway, Executive Vice President, Ascend Laboratories, a seasoned leader with decades of experience in the generics industry.
- Amit Ghare, Ascend Laboratories.
- Jeff Woldt, Editor-in-Chief, retailmediaIQ, will moderate the conversation.
This is a unique opportunity to gain insider perspectives on the business and policy shifts shaping the future of generic medications and patient access to affordable treatments.
